Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.

Mitchell, S M; Membrey, W L; Youle, M S; Obi, A; Worrell, S; Gazzard, B G

Mitchell, S M; Membrey, W L; Youle, M S; Obi, A; Worrell, S; Gazzard, B G.

Affiliation

Mitchell SM; Department of Ophthalmology, St Stephen's Centre, Chelsea and Westminster Hospital, London.

Br J Ophthalmol ; 83(6): 652-5, 1999 Jun.

Article in En | MEDLINE | ID: mdl-10340970

Subject(s)

Cytomegalovirus Retinitis/drug therapy; HIV Protease Inhibitors/therapeutic use; Indinavir/therapeutic use; AIDS-Related Opportunistic Infections/complications; CD4 Lymphocyte Count/drug effects; Cohort Studies; Cytomegalovirus Retinitis/complications; Cytomegalovirus Retinitis/immunology; Drug Therapy, Combination; HIV/isolation & purification; Humans; Prospective Studies; Treatment Outcome; Viral Load

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: HIV Protease Inhibitors / Cytomegalovirus Retinitis / Indinavir Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 1999 Type: Article

Fulltext

XML

PubMed Links

Search on Google